NCT00123084

Brief Summary

The purpose of the research study is to determine the effects of two different kinds of speech treatment on certain behaviors in individuals with parkinson's disease. These behaviors include speech, voice, related communication behaviors, swallowing and body movement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
620

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2002

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2002

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 22, 2005

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2012

Completed
Last Updated

July 31, 2018

Status Verified

April 1, 2017

Enrollment Period

10.6 years

First QC Date

July 20, 2005

Last Update Submit

July 27, 2018

Conditions

Keywords

Parkinson's diseaseSwallowing difficultiesspeechvoice

Outcome Measures

Primary Outcomes (1)

  • Voice intensity; voice fundamental frequency; articulatory acoustics; physiological voice function; speech intelligibility; swallowing function; non-verbal communication behaviors; limb function; neural imaging; neuropsychological functioning

    8-9 months

Study Arms (4)

Voice/Respiratory Treatment

EXPERIMENTAL

4 Days a week for 4 weeks with focus on high intensity voice exercises

Behavioral: Voice/Respiration Treatment

Articulation Treatment

EXPERIMENTAL

4 days a week for 4 weeks with focus on high intensity articulation tasks

Behavioral: Speech/Articulation Treatment

Subjects with PD in a no treatment group

NO INTERVENTION

Subjects do not receive therapy during experimental phases, and will be offered therapy at the end of the study enrollment period.

Healthy Control Subjects

NO INTERVENTION

Subjects are without Parkinson disease and will not receive therapy.

Interventions

Therapy is 4 1-hour sessions per week for 4 weeks. Tasks include high-effort exercises focusing on increased loudness and good voice quality.

Also known as: LSVT LOUD
Voice/Respiratory Treatment

Therapy is 4 1-hour sessions per week for 4 weeks. Tasks include high-effort articulation exercises to promote more enunciated speech.

Also known as: LSVT ARTIC
Articulation Treatment

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Idiopathic Parkinson's Disease (IPD)
  • None or mild dementia
  • None, mild or moderate depression
  • Mild, moderate or severe speech, voice, and swallowing disorder

You may not qualify if:

  • Severe depression
  • Moderate or severe dementia
  • Symptoms of another neurological condition other than or in addition to IPD or drug abuse
  • Head or neck cancer
  • Significant history of gastrointestinal disease or surgery
  • Speech or voice disorders unrelated to IPD
  • Neurosurgery, not for management of PD symptoms
  • Laryngeal pathology/surgery
  • Full-course Lee Silverman Voice Treatment (LSVT®)
  • Smoked in last four years
  • Absence of speech, voice or swallowing disorder
  • Severe temporomandibular joint disorder
  • Pregnancy (or the possibility of pregnancy)
  • Hearing loss unexpected for his/her chronological age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Center for Voice and Speech-Denver; An Affiliate of the unniversity of Colorado

Denver, Colorado, 80204, United States

Location

University of Texas HSC San Antonio

San Antonio, Texas, United States

Location

Related Publications (1)

  • Levy ES, Moya-Gale G, Chang YHM, Freeman K, Forrest K, Brin MF, Ramig LA. The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial. EClinicalMedicine. 2020 Jun 28;24:100429. doi: 10.1016/j.eclinm.2020.100429. eCollection 2020 Jul.

MeSH Terms

Conditions

Parkinson DiseaseDeglutition DisordersDysarthriaSpeech

Interventions

Voice

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesArticulation DisordersSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVerbal BehaviorCommunicationBehavior

Intervention Hierarchy (Ancestors)

Respiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Lorraine Ramig, PhD, CCC-SLP

    Professor, University of Colorado-Boulder; Senior Scientist, National Center for Voice and Speech-Denver; Adjunct Professor, Columbia University-NYC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2005

First Posted

July 22, 2005

Study Start

March 1, 2002

Primary Completion

September 30, 2012

Study Completion

September 30, 2012

Last Updated

July 31, 2018

Record last verified: 2017-04

Locations